Ser793

Site Information
DVAPtLMsVPRyLPR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 34502436

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Disease tissue studied:	breast cancer ( 3 , 6 ) , breast ductal carcinoma ( 3 ) , HER2 positive breast cancer ( 1 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, surrounding tissue ( 1 ) , breast cancer, triple negative ( 1 , 3 ) , lung cancer ( 2 , 5 , 6 ) , non-small cell lung cancer ( 6 ) , non-small cell lung adenocarcinoma ( 2 , 5 )
Relevant cell line - cell type - tissue:	breast ( 1 , 3 ) , BT-20 (breast cell) ( 6 ) , H2077 (pulmonary) ( 6 ) , H322M (pulmonary) ( 6 ) , HCC1937 (breast cell) ( 6 ) , liver ( 4 ) , lung ( 5 ) , MCF-7 (breast cell) ( 6 ) , MDA-MB-468 (breast cell) ( 6 ) , PC9 (pulmonary) ( 2 )

References
1	Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 27251275 Curated Info
2	Tsai CF, et al. (2015) Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics. Nat Commun 6, 6622 25814448 Curated Info
3	Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704 24719451 Curated Info
4	Bian Y, et al. (2014) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics 96, 253-62 24275569 Curated Info
5	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info
6	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info